As shown in Figure 2, more than 50% of tumors cells showed HER2 staining of 3+, along with reduced ER and PR expression, while the rest of the tumor showed moderate HER2 protein expression (2+) accompanied with higher expression of ER and PR. This evidence concerns the gene ERBB2 and neoplasm.